Capital Investment Advisors, LLC Merck & Co., Inc. Transaction History

Capital Investment Advisors, LLC

$4.79 Billion
Q3 2024

A detailed history of Capital Investment Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 317,694 shares of MRK stock, worth $31.3 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

317,694

Previous 315,810 0.6%

Holding current value

$31.3 Million

Previous $39.1 Million 7.72%

% of portfolio

0.75%

Previous 0.89%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$111.15 - $128.97 $209,406 - $242,979	1,884 Added 0.6%	317,694 $36.1 Million
Q2 2024 Jul 12, 2024	SELL	$123.8 - $132.96 $45,682 - $49,062	-369 Reduced 0.12%	315,810 $39.1 Million
Q1 2024 Apr 15, 2024	BUY	$113.24 - $131.95 $86,062 - $100,281	760 Added 0.24%	316,179 $41.7 Million
Q4 2023 Jan 05, 2024	BUY	$100.18 - $109.02 $27,349 - $29,762	273 Added 0.09%	315,419 $34.4 Million
Q3 2023 Oct 16, 2023	BUY	$102.95 - $114.33 $32.4 Million - $36 Million	315,146 New	315,146 $32.4 Million
Q1 2023 Apr 10, 2023	BUY	$102.94 - $114.86 $1.64 Million - $1.83 Million	15,952 Added 4.24%	392,090 $41.7 Million
Q4 2022 Jan 05, 2023	BUY	$87.44 - $112.11 $4.32 Million - $5.54 Million	49,374 Added 15.11%	376,138 $41.7 Million
Q3 2022 Oct 05, 2022	BUY	$84.53 - $94.96 $1.36 Million - $1.53 Million	16,063 Added 5.17%	326,764 $28.1 Million
Q2 2022 Jul 06, 2022	BUY	$83.49 - $94.64 $658,903 - $746,898	7,892 Added 2.61%	310,701 $28.3 Million
Q1 2022 Apr 13, 2022	BUY	$73.51 - $82.4 $358,434 - $401,782	4,876 Added 1.64%	302,809 $24.8 Million
Q4 2021 Jan 10, 2022	SELL	$72.28 - $90.54 $949,542 - $1.19 Million	-13,137 Reduced 4.22%	297,933 $22.8 Million
Q3 2021 Oct 13, 2021	BUY	$71.68 - $78.83 $1.17 Million - $1.29 Million	16,331 Added 5.54%	311,070 $23.4 Million
Q2 2021 Jul 14, 2021	BUY	$70.31 - $77.77 $1.61 Million - $1.78 Million	22,893 Added 8.42%	294,739 $22.9 Million
Q1 2021 Apr 27, 2021	BUY	$68.86 - $81.11 $2.22 Million - $2.62 Million	32,249 Added 13.46%	271,846 $21 Million
Q4 2020 Jan 21, 2021	BUY	$71.77 - $79.65 $2.18 Million - $2.42 Million	30,402 Added 14.53%	239,597 $19.6 Million
Q3 2020 Oct 29, 2020	BUY	$73.18 - $82.95 $3.42 Million - $3.88 Million	46,760 Added 28.79%	209,195 $17.4 Million
Q2 2020 Jul 20, 2020	BUY	$70.42 - $80.13 $791,239 - $900,340	11,236 Added 7.43%	162,435 $12.6 Million
Q1 2020 Apr 13, 2020	BUY	$63.36 - $87.82 $1.85 Million - $2.57 Million	29,271 Added 24.01%	151,199 $11.6 Million
Q4 2019 Jan 21, 2020	SELL	$77.58 - $87.54 $199,458 - $225,065	-2,571 Reduced 2.07%	121,928 $11.1 Million
Q3 2019 Oct 24, 2019	SELL	$76.08 - $82.93 $642,495 - $700,343	-8,445 Reduced 6.35%	124,499 $10.5 Million
Q2 2019 Jul 17, 2019	SELL	$69.84 - $81.59 $41,065 - $47,974	-588 Reduced 0.44%	132,944 $11.1 Million
Q1 2019 Apr 11, 2019	SELL	$69.58 - $79.36 $485,042 - $553,218	-6,971 Reduced 4.96%	133,532 $11.1 Million
Q4 2018 Jan 17, 2019	SELL	$65.24 - $75.71 $1.16 Million - $1.35 Million	-17,818 Reduced 11.25%	140,503 $10.7 Million
Q3 2018 Oct 15, 2018	BUY	$57.69 - $67.84 $31,267 - $36,769	542 Added 0.34%	158,321 $11.2 Million
Q2 2018 Jul 10, 2018	BUY	$50.83 - $59.72 $970,497 - $1.14 Million	19,093 Added 13.77%	157,779 $9.58 Million
Q1 2018 Apr 16, 2018	BUY	$50.96 - $59.23 $2.6 Million - $3.02 Million	50,976 Added 58.12%	138,686 $7.55 Million
Q4 2017 Jan 17, 2018	BUY	$51.62 - $61.64 $1.17 Million - $1.4 Million	22,754 Added 35.03%	87,710 $4.94 Million
Q3 2017 Oct 17, 2017	BUY	$58.67 - $63.13 $3.81 Million - $4.1 Million	64,956	64,956 $4.16 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.

Account

Capital Investment Advisors, LLC Merck & Co., Inc. Transaction History